The following public datasets were used in this study:

* The transcriptionally profile of 35,276 individual cells from 32 breast cancer cell lines reported by Gambardella, G., et al. *"A single-cell atlas of breast cancer cell lines to study tumour heterogeneity and drug response."* Nature Communications (2022). Accessed through: DOI, record: [10.6084/m9.figshare.15022698](https://figshare.com/ndownloader/files/28893384)
* The transcriptional profile of 14,372 wild-type cells from the MCF7 cell line reported by Ben-David, Uri, et al. *"Genetic and transcriptional evolution alters cancer cell line drug response."* Nature 560.7718 (2018): 325-330. Accessed through: GEO, accession number: [GSE114459](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE114459)
* The transcriptional profile of 491 single-cells derived from the T47D cell line with a CRISPR knockout of the *CDH1* gene reported by Chen, Fangyuan, et al. *"Single-cell transcriptomic heterogeneity in invasive ductal and lobular breast cancer cells."* Cancer research 81.2 (2021): 268-281. Accessed through:  GEO, accession number: [GSE144320](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE144320)
* The transcriptional profile of 131 single-cells derived from the BT474 cell line and treated with 1 uM of Lapatinib for 10 days reported by Oren, Yaara, et al. *"Cycling cancer persister cells arise from lineages with distinct programs."* Nature 596.7873 (2021): 576-582. Accessed through: GEO, accession number: [GSE150949](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE150949)
* The transcriptional profile of 130,246 annotated single cells from 26 primary tumors reported by Wu, Sunny Z., et al. *"A single-cell and spatially resolved atlas of human breast cancers."* Nature genetics 53.9 (2021): 1334-1347. Accessed through: GEO, accession number: [GSE176078](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE176078)
* The synergistic effect, potency and efficacy of 2,025 clinically relevant two-drug combinations for 51 breast cancer, 45 colorectal and 29 pancreatic cell lines reported by Jaaks, Patricia, et al. *"Effective drug combinations in breast, colon and pancreatic cancer cells."* Nature (2022): 1-8. Accessed through: DOI, record: [10.6084/m9.figshare.19141928](https://doi.org/10.6084/m9.figshare.19141928.v1)
